Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Miebo (Perfluorohexyloctane) Eyedrops in Habitual Contact Lens Wearers

NCT06176651 is registered in ClinicalTrials.gov with Gordon Schanzlin New Vision as lead sponsor.

NCT NCT06176651
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06176651 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Miebo (Perfluorohexyloctane) Eyedrops in Habitual Contact Lens Wearers
Lead sponsor
Gordon Schanzlin New Vision
Phase
Phase 4
Overall status
Completed
Start date
September 21, 2023
Completion date
April 5, 2024
Enrollment
49 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye, dry eye disease, dry eye, evaporative, evaporative dry eye, evaporative dry eye disease, kerato conjunctivitis sicca